Doxorubicin- and daunorubicin-induced energy deprivation and nucleotide degradation in isolated cardiomyocytes

Toxicology

Volumn 114, Issue 1, 1996, Pages 1-10

  Vidal, Ricardo F ^a   Eksborg, Staffan ^b   Sundberg, Monica ^a   Carlberg, Magdalena ^a   Elfsson, Birgitta ^b   Andersson, Bo S ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

ATP depletion; Cardiomyocytes; Cytotoxicity; Daunorubicin; Doxorubicin; Metabolism

Indexed keywords

ADENOSINE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; DAUNORUBICIN; DAUNORUBICINOL; DOXORUBICIN; DRUG METABOLITE; INOSINE; NICOTINAMIDE ADENINE DINUCLEOTIDE;

ANIMAL CELL; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOCHEMISTRY; CYTOSOL; CYTOTOXICITY; DRUG METABOLISM; HEART MUSCLE CELL; IN VITRO STUDY; MALE; MITOCHONDRION; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RAT;

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CELL SEPARATION; CELL SURVIVAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTOSOL; DAUNORUBICIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; HEART; MALE; MYOCARDIUM; NADP; OXYGEN CONSUMPTION; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA;

EID: 0030589122     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(96)03410-5     Document Type: Article

References (33)

1. Allen, A. (1992) The cardiotoxicity of chemotherapeutic drugs. Semin. Oncol. 19, 529-542.
2. Andersson, B.S., Vidal, R.F., Sundberg, M., Rajs, J. and Sótonyi, P. (1996) Hydroperoxide-induced nucleotide degradation and adenosine formation in isolated rat cardiomyocytes. Toxicology 106, 39-48.
3. Atkinson, D.E. (1970) Enzymes as control elements in metabolic regulation. In: P.D. Boyer (Ed.), The Enzymes, Academic Press, New York, pp. 461-489.
4. 2+ transport in rat heart mitochondria. Toxicol. Lett. 3, 29-34.
5. Bachmann, E., Weber, E. and Zbinden, G. (1975) Effects of seven anthracycline antibiotics on electrocardiogram and mitochondrial function of rat hearts. Agents Actions 5/4, 383-393.
6. Bachmann, E., Weber, E. and Zbinden, G. (1987) Effects of mitoxantrone and doxorubicin on energy metabolism of the rat heart. Cancer Treat. Rep. 71, 361-366.
7. Bachur, N.R., Hildebrand, R.C. and Jaenke, R.S. (1974) Adriamycin and daunomycin disposition in the rabbit. J. Pharmacol. Exp. Ther. 191, 331-340.
8. Bachur, N.R., Gordon, S.L. and Gee, M.V. (1977) Anthracycline antibiotic augmentation of microsomal electron transport and free radical formation. Mol. Pharmacol. 13, 901-910.
9. Bristow, M.R., Kantrowitz, N.E., Harrison, W.D., Minobe, W.A., Sageman, W.S. and Billingham, M.E. (1983) Mediation of subacute anthracycline cardiotoxicity in rabbits by cardiac histamine release. J. Cardiovasc. Pharmacol. 5, 913-919.
10. Burger, R.M. and Lowenstein, J.M. (1975) 5′Nucleotidase from smooth muscle of small intestine and from brain. Inhibition by nucleotides. Biochemistry 14, 2362-2366.
11. Cini Neri, G., Neri, B., Bandinelli, M., Del Tacca, M., Danesi, R. and Riccardi, R. (1991) Anthracycline cardiotoxicity: In vivo and in vitro effects on biochemical parameters and heart ultrastructure of the rat. Oncology 48, 327-333.
12. Collinson, A.R., Peuhkurinen, K.J. and Lowenstein, J.M. (1987) Regulation and function of 5′nucleotidases. In: E. Gerlach and B.F. Becker (Eds.), Topics and Perspectives in Adenosine Research, Springer-Verlag, Berlin, pp. 133-144.
13. Cusack, B.J., Mushlin, P.S., Voulelis, L.D., Li, X., Boucek Jr, R.J. and Olson, R.D. (1993) Daunorubicin-induced cardiac injury in the rabbit: A role for daunorubicinol? Toxicol. Appl. Pharmacol. 118, 177-185.
14. Dallal, G.E. (1988) PITMAN: A FORTRAN program for exact randomization tests. Comput. Biomed. Res. 21, 9-15.
15. Daniel, W.W. (Ed.) (1978) Applied Nonparametric Statistics, Houghton Mifflin Company, Boston.
16. Del Tacca, M., Danesi, R., Ducci, M., Bernardini, C. and Romanini, A. (1985) Might adriamycinol contribute to adriamycin-induced cardiotoxicity? Pharmacol. Res. Commun. 17, 1073-1084.
17. Eksborg, S., Ehrsson, H., Andersson, B. and Beran, M. (1978) Liquid chromatographic determination of daunorubicin and daunorubicinol in plasma from leukemic patients. J. Chromatogr. 153, 211-218.
18. Eksborg, S., Ehrsson, H. and Andersson, I. (1979) Reversed-phase liquid chromatographic determination of plasma levels of adriamycin and adriamycinol. J. Chromatogr. 164, 479-486.
19. Felsted, R.L., Malcolm, G. and Bachur, N.R. (1974) Rat liver daunomycin reductase. An aldo-keto reductase. J. Biol. Chem. 249, 3672-3679.
20. Ferrero, M.E., Ferrero, E., Gaja, G. and Bernelli-Zazzera, A. (1976) Adriamycin: Energy metabolism and mitochondrial oxidations in the heart of treated rabbits. Biochem. Pharmacol. 25, 125-130.
21. Geisbuhler, T., Altschuld, R.A., Trewyn, R.W., Ansel, A.Z., Lamka, K. and Brierley, G.P. (1984) Adenine nucleotide metabolism and compartmentalization in isolated adult rat heart cells. Circ. Res. 54, 536-546.
22. Haworth, R.A., Goknur, A.B., Cook, M.G. and Decker, R.S. (1990) Use of isolated adult myocytes to evaluate cardiotoxicity. I. Sugar uptake and protein synthesis. Toxicol. Pathol. 18, 511-520.
23. Maser, E. (1995) Xenobiotic carbonyl reduction and physiological steroid oxidoreduction. The pluripotency of several hydroxysteroid dehydrogenases. Biochem. Pharmacol. 49, 421-440.
24. Nicolay, K. and Kruijff, B. (1987) Effects of adriamycin on respiratory chain activities in mitochondria from rat liver/rat heart and bovine heart. Evidence of a preferential inhibition of complex III and IV. Biochim. Biophys. Acta 892, 320-330.
25. Ohara, H., Miyabe, Y., Deyashiki, Y., Matsuura, K. and Hara A. (1995) Reduction of drug ketones by dihydrodiol dehydrogenases, carbonyl reductase and aldehyde reductase of human liver. Biochem. Pharmacol. 50, 221-227.
26. Olson, R.D., Mushlin, P.S., Brenner, D.E., Fleischer, S., Cusack, B.J., Chang, B.K. and Boucek Jr, R.S. (1988) Doxorubicin cardiotoxicity may be caused by its metabolite, doxorubicinol. Proc. Natl. Acad. Sci. USA 85, 3585-3589.
27. Papadopoulou, L.C. and Tsiftsoglou, A.S. (1993) Mitochondrial cytochrome c oxidase as a target site for daunomycin in K-562 cells and heart tissue. Cancer Res. 53, 1072-1078.
28. Paul, C., Tomingas, A., Rajs, J., Anundi, I., Högberg, J. and Peterson, C. (1982) Toxic effects of free and DNA-linked daunorubicin on isolated rat cardiac myocytes. Acta Pharmacol. Toxicol. 51, 292-299.
29. Salmon, S.E. and Sartorelli, A.C. (1987) Cancer chemotherapy- antibiotics. In: B.G. Katzung (Ed.), Basic and Clinical Pharmacology, Appleton and Lange, Norwalk, pp. 678-682.
30. Singal, P.K., Deally, C.M.R. and Weinberg, L.E. (1987) Subcellular effects of adriamycin in the heart: a concise review. J. Mol. Cell. Cardiol. 19, 817-828.
31. Solem, L.E., Henry, T.R. and Wallace, K.B. (1994) Disruption of mitochondrial calcium homeostasis following chronic doxorubicin administration. Toxicol. Appl. Pharmacol. 129, 214-222.
32. Takanashi, S. and Bachur, N.R. (1976) Adriamycin metabolism in man. Evidence from urinary metabolites. Drug Metab. Dispos. 4, 79-87.
33. Von Wartburg, J.P. and Wermuth, B. (1980) Aldehyde reductase. In: W.B. Jacoby (Ed.), Enzymatic Basis of Detoxication, Vol. 1, Academic Press, New York, pp. 249-260.